化生性乳腺癌一例
摘要
患者女,40岁,已婚,因“发现右乳包块、乳头溢血2月”入院,查体:右乳扪及一大小约7.0cm×7.0cm包块,活动性大,边界清楚,表面光滑,质硬,与周围组织轻度粘连,轻度压痛,无侵及皮肤表现。B超示右乳巨大无回声混合型占位性病变,可探及血流信号。钼靶示右乳巨大团块影,密度较高而均匀。
出处
《中华普通外科杂志》
CSCD
北大核心
2010年第8期610-610,共1页
Chinese Journal of General Surgery
参考文献4
-
1马日海,汪建初,浦涧.乳腺癌肉瘤10例临床诊治分析[J].实用医学杂志,2007,23(10):1521-1521. 被引量:9
-
2Smith,DM,Rongaus VA,Wehmann TW,et al.Metaplastic breast carcinoma.J Am Osteopath Assoc,1996:96:419-421.
-
3孙正魁,马行天,吴毓东,樊帆,万向华,付爱荣.三阴乳腺癌对含蒽环类方案新辅助化疗的反应及远期疗效[J].中国肿瘤临床,2009,36(3):126-130. 被引量:14
-
4Carter MR,Hornick JL,Lester S,et al.Spindle cell (sarcomatold) carcinoma of the breast:a clinicopathologic and immunohistochemical analysis of 29 cases.Am J Surg Pathol,2006,30:300-309.
二级参考文献18
-
1牛昀,傅西林.乳腺癌肉瘤(附7例病理及临床分析)[J].中国肿瘤临床,1993,20(9):674-676. 被引量:4
-
2Rakha EA, El-Rehim DA, Paish C, et al. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance[]]. Eur J Cancer, 2006, 42(18): 3149-3156.
-
3Carey LA, Dees EC, Sawyer L, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes[J]. Clin Cancer Res, 2007, 13(8): 2329-2334.
-
4Carey LA, Metzger R, Dees EG, et al. American Joint Committee on Cancer tumor-node-metastasls stage after neoadjuvant chemotherapy and breast cancer outcome[J]. J Natl Cancer Inst, 2005 97(15): 1137-1142.
-
5Ghollet P, Amat S, Belembaogo E, et al. Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer[J]? BrJ Gancer, 2003, 89(7): 1185-1191.
-
6Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer[J]. Cancer, 2007, 109(1):25-32.
-
7Mieog JS, van der Hage JA, van de Velde CJ. Neoadjuvant chemotherapy for operable breast cancer[J]. Br J Surg, 2007, 94 (10): 1189-1200.
-
8Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy [J]. Clin Cancer Res, 2005, 11(16): 5678-5685.
-
9Umemura S, Takekoshi S, Suzuki Y, et al. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression[J]. Oncol Rep, 2005, 14(2): 337-343.
-
10Bhatavdekar JM, Patel DD, Shah NG, et al. Prognostic significance of immunohistochemically localized biomarkers in stage Ⅱ and stage Ⅲ breast cancer:a multivariate analysis[J]. Ann Surg Oncol, 2000, 7(4): 305-311.
共引文献21
-
1陈画华,庄丽华,高月平.护理干预对乳腺癌放疗患者疾病不确定感的影响[J].实用医学杂志,2007,23(22):3623-3624. 被引量:6
-
2袁媛,费乐学,刘岩,邢朝斌.基质金属蛋白酶-3与细胞外基质金属蛋白酶诱导因子在乳腺癌演变过程中的表达及意义[J].实用医学杂志,2008,24(1):10-13. 被引量:5
-
3吴俊,曹永政,彭格红,曾红艳.高频彩色多普勒超声在乳腺癌徒手穿刺活检中的应用[J].实用医学杂志,2008,24(5):881-881. 被引量:1
-
4张毅,曹明智.乳腺癌肉瘤的临床特点与病理生物学特性[J].中华普通外科学文献(电子版),2009,3(6):39-42. 被引量:12
-
5王纯,雷艳荣,卢宏达.TAC方案术前辅助化疗对三阴性乳腺癌的疗效观察[J].浙江临床医学,2011,13(4):376-378. 被引量:1
-
6王朝霞.紫杉醇联合蒽环类新辅助化疗方案治疗三阴乳腺癌的疗效观察[J].中国医疗前沿,2011,6(16):49-50. 被引量:10
-
7李慧,姜达.三阴性乳腺癌的研究进展[J].肿瘤基础与临床,2011,24(6):540-543. 被引量:1
-
8郑永忠.乳腺癌新辅助化疗疗效与TopoⅡ变化的临床研究[J].现代预防医学,2012,39(24):6397-6398. 被引量:2
-
9施永胜,孙鑫鑫,钟献.年轻女性乳腺癌中ER、PR、HER-2和Ki67的表达与临床病理意义研究[J].中国现代医生,2012,50(36):115-116. 被引量:2
-
10章克毅,张仕义,吴智勇,傅俊惠,郑海波,郑春鹏,黄建豪,陈捷鑫,沈金辉.可手术三阴乳腺癌对两种新辅助化疗方案的临床近期疗效比较[J].广东医学,2013,34(23):3618-3620. 被引量:25
-
1阚秀.化生性乳腺癌[J].中国肿瘤临床,1998,25(9):688-690. 被引量:9
-
2杨勇,汪琳.化生性乳腺癌1例[J].黔南民族医专学报,2010,23(3):215-215.
-
3洪景辉,付彤,赵刚,贾泓瑶,刘瑞东,宋东.化生性乳腺癌的研究进展[J].吉林大学学报(医学版),2016,42(4):839-842. 被引量:1
-
4刘彩云,马振峰,问明,崔乃鹏,陈保平.化生性乳腺癌1例报道[J].中国肿瘤外科杂志,2013,5(5):332-333.
-
5贾国丛,李孟圈,李建章.126例乳头溢血临床分析[J].肿瘤基础与临床,2006,19(5):405-406.
-
6胡昕鹏,陈国学.化生性乳腺癌一例[J].临床外科杂志,2015,23(11):880-880. 被引量:1
-
7尚文博,张丽娜,李春晓,李云涛,李海平,范忠林.化生性乳腺癌23例临床分析[J].中华普通外科杂志,2013,28(10):799-800. 被引量:1
-
8高月,张清媛.化生性乳腺癌的研究进展[J].临床肿瘤学杂志,2014,19(8):759-762. 被引量:7
-
9丁华野,皋岚湘.化生性乳腺癌的诊断和鉴别诊断[J].浙江肿瘤,1996,2(4):199-202. 被引量:2
-
10赵阳,韩正祥,高向阳,杜秀平.化生性乳腺癌1例[J].徐州医学院学报,2009,29(3):188-188.